Working together with patient groups

The aim of this document is to underline the rationale for interactions between the pharmaceutical industry and Patient Organisations, suggest the principles on which these interactions should be based, outline the points of collaboration through the life cycle of a medicine, discuss some of the challenges and potential solutions to interact as well as providing a list of resources to support meaningful/appropriate collaboration. 

This document was co-created by representatives of Patient Organisations and the research-based pharmaceutical industry through the EFPIA Patient Think Tank with support from EFPIA’s Ethics and Compliance Committee.